Gene DX INC:1108521 [16-016944]
Ended Awarded
- Contract number
- HHSN26100002
- Awardee
-
Genedx, LLC UEI H3J4SCC8F671
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,250
Award facts
- Opportunity
-
- N02CP5261224 Solicitation number
- CLIA-certified clinical genetic testing for TP53 Award Notice · Posted Jun 23, 2015
- Contract value 100% obligated
- $5,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic categories. Genedx has a long-standing relationship with NIH, having been registered to receive federal awards since 2008. The company has been awarded several Indefinite Delivery Vehicles (IDVs) by the NIH Clinical Center to provide on-demand access to its specialized genetic testing capabilities, supporting ongoing research and patient care initiatives. This contract award is part of Genedx's broader work with NIH, contributing de-identified genetic data and variant analysis to grant-funded projects, such as the Channelopathy-Associated Epilepsy Research Center.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to Genedx, LLC by National Cancer Institute (National Institutes of Health) on January 12, 2016.
How much is contract HHSN26100002 worth?
The government has obligated $5,250 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201500016I, an indefinite delivery contract.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award